197 related articles for article (PubMed ID: 34437574)
1. Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease.
Choi Y; Sim S; Lee DH; Lee HR; Ban GY; Shin YS; Kim YK; Park HS
PLoS One; 2021; 16(8):e0256237. PubMed ID: 34437574
[TBL] [Abstract][Full Text] [Related]
2. Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease.
Choi Y; Lee DH; Trinh HKT; Ban GY; Park HK; Shin YS; Kim SH; Park HS
Allergy; 2019 Jan; 74(1):78-88. PubMed ID: 29663427
[TBL] [Abstract][Full Text] [Related]
3. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M
Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
[TBL] [Abstract][Full Text] [Related]
4. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease.
Trinh HKT; Pham DL; Choi Y; Kim HM; Kim SH; Park HS
Clin Exp Allergy; 2018 Nov; 48(11):1464-1473. PubMed ID: 30126026
[TBL] [Abstract][Full Text] [Related]
5. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
[TBL] [Abstract][Full Text] [Related]
7. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.
Comhair SAA; Bochenek G; Baicker-McKee S; Wang Z; Stachura T; Sanak M; Hammel JP; Hazen SL; Erzurum SC; Nizankowska-Mogilnicka E
Respir Res; 2018 Oct; 19(1):210. PubMed ID: 30376852
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.
Choi GS; Kim JH; Shin YS; Ye YM; Kim SH; Park HS
Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma.
Kawagishi Y; Mita H; Taniguchi M; Maruyama M; Oosaki R; Higashi N; Kashii T; Kobayashi M; Akiyama K
J Allergy Clin Immunol; 2002 Jun; 109(6):936-42. PubMed ID: 12063521
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease.
Ban GY; Cho K; Kim SH; Yoon MK; Kim JH; Lee HY; Shin YS; Ye YM; Cho JY; Park HS
Clin Exp Allergy; 2017 Jan; 47(1):37-47. PubMed ID: 27533637
[TBL] [Abstract][Full Text] [Related]
11. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
[TBL] [Abstract][Full Text] [Related]
12. Biological effects of leukotriene E4 on eosinophils.
Steinke JW; Negri J; Payne SC; Borish L
Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):105-10. PubMed ID: 24768603
[TBL] [Abstract][Full Text] [Related]
13. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
Liu T; Barrett NA; Kanaoka Y; Yoshimoto E; Garofalo D; Cirka H; Feng C; Boyce JA
J Immunol; 2018 Feb; 200(3):915-927. PubMed ID: 29282304
[TBL] [Abstract][Full Text] [Related]
14. Factors driving the aspirin exacerbated respiratory disease phenotype.
Steinke JW; Borish L
Am J Rhinol Allergy; 2015; 29(1):35-40. PubMed ID: 25590316
[TBL] [Abstract][Full Text] [Related]
15. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes.
Laidlaw TM; Kidder MS; Bhattacharyya N; Xing W; Shen S; Milne GL; Castells MC; Chhay H; Boyce JA
Blood; 2012 Apr; 119(16):3790-8. PubMed ID: 22262771
[TBL] [Abstract][Full Text] [Related]
16. Update on recent advances in the management of aspirin exacerbated respiratory disease.
Palikhe NS; Kim JH; Park HS
Yonsei Med J; 2009 Dec; 50(6):744-50. PubMed ID: 20046412
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma.
Bochenek G; Stachura T; Szafraniec K; Plutecka H; Sanak M; Nizankowska-Mogilnicka E; Sladek K
J Allergy Clin Immunol Pract; 2018; 6(2):528-535. PubMed ID: 28888846
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort.
Lee Y; Kim C; Lee E; Lee HY; Woo SD; You SC; Park RW; Park HS
Clin Exp Allergy; 2023 Sep; 53(9):941-950. PubMed ID: 37332228
[TBL] [Abstract][Full Text] [Related]
19. Persistent Eosinophilic Inflammation in Adult Asthmatics with High Serum and Urine Levels of Leukotriene E
Ban GY; Kim SH; Park HS
J Asthma Allergy; 2021; 14():1219-1230. PubMed ID: 34675552
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil production of prostaglandin D
Feng X; Ramsden MK; Negri J; Baker MG; Payne SC; Borish L; Steinke JW
J Allergy Clin Immunol; 2016 Oct; 138(4):1089-1097.e3. PubMed ID: 27423494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
